Daily Schedule Home

Saturday, November 9, 2024

Times and topics subject to change. All times in Central Standard Time. 

TimeSession/TopicLocation/Presenter
6:00 a.m. - 6:30 p.m.Attendee RegistrationLonghorn Marble Foyer
6:00 a.m. - 12:30 p.m.Exhibitor RegistrationLonghorn Marble Foyer
Sponsor Lounges OpenCenter Pre-Function (Level 3)
6:00 a.m. - 6:45 a.m.AAHKS Committee Breakfast
For AAHKS Committee Members only
Grapevine Ballroom A
6:00 a.m. - 7:30 a.m.Breakfast for All Attendees Exhibit Hall/Learning Center
Longhorn Exhibition Hall C–F
7:00 a.m. - 2:00 p.m.Exhibit Hall/Learning Center OpenExhibit Hall/Learning Center
Longhorn Exhibition Hall C–F
7:00 a.m. - 2:00 p.m.Scientific Poster Exhibition OpenExhibit Hall/Learning Center
Longhorn Exhibition Hall C–F
9:00 a.m. - 5:00 p.m.AAHKS Shop Open Center Pre-Function (Level 3)
6:55 a.m. - 6:27 p.m.AAHKS General SessionTexas Ballroom
6:55 a.m. - 7:00 a.m.Program Chair’s Welcome to the 2024 Annual Meeting
Jonathan M. Vigdorchik, MD
7:00 a.m. - 7:34 a.m.Session Two:
Perioperative Optimization
Moderators: Michael J. Taunton, MD
Claudette M. Lajam, MD
7:00 a.m.Paper #11
GLP-1 Receptor Agonist Utilization at the Time of THA for Patients with Morbid Obesity
Gwo-Chin Lee, MD
New York, NY
7:06 a.m.Paper #12
Optimal Timing for Cessation of GLP-1 Agonist before Elective TJA
Christopher T. Holland, MD, MS
Memphis, TN
7:12 a.m.Paper #13
GLP-1 Receptor Agonist Mediated Weight Loss Improves Outcomes After TKA
Vishal Hegde, MD
Baltimore, MD
7:18 a.m.Paper #14
GLP-1 Receptor Agonists Decrease Postoperative Complications Following TKA
Joshua S. Bingham, MD
Phoenix, AZ
7:24 a.m.DiscussionAll Faculty
7:34 a.m. - 8:34 a.m.Symposium III: Patient Preoperative Optimization: How to Do It and How to Be Paid for the Work Moderator: Kevin B. Fricka, MD
8:34 a.m. – 8:54 a.m. Break
Exhibit Hall/Learning Center
Longhorn Exhibition Hall C–F
8:54 a.m. - 9:56 a.m.Session Three: Revision TKAModerators: Matthew P. Abdel, MD
Elizabeth B. Gausden, MD, MPH
8:54 a.m.Paper #15
Comparison of Survivorship of Distal Femoral Replacements by Fixation Method
Yale A. Fillingham, MD
Philadelphia, PA
9:00 a.m.Paper #16
Prior Canal Instrumentation Is a Major Risk Factor for Fixation Failure after DFR
Andrew J. Hughes, MD, FRCS
New York, NY
9:06 a.m.Paper #17
Outcomes Following Distal Femur Replacement: A Multi-Institutional Retrospective Review
David C. Landy, MD, PhD
Memphis, TN
9:12 a.m.Paper #18
575 Rotating-Hinge TKAs: Surprisingly Low Rates of Aseptic Loosening
E. Bailey Terhune, MD
Rochester, MN
9:18 a.m.DiscussionAll Faculty
9:28 a.m.Paper #19
Mid-Term Clinical Outcomes in Revision TKA for Flexion Instability
Luke R. Lovro, MD
Indianapolis, IN
9:34 a.m.
Paper #20
Does UKA Failure Mode Impact Conversion TKA Outcomes?
Robert A. Sershon, MD
Alexandria, Virgina
9:40 a.m.
Paper #21
Intraosseous Vancomycin Reduces the Rate of PJI Following Aseptic Revision TKA
Colin A. McNamara, MD, MBA
Miami, FL
9:46 a.m.
DiscussionAll Faculty
9:56 a.m.American Joint Replacement Registry (AJRR) Update James I. Huddleston III, MD
10:01 a.m. – 10:46 a.m.Symposium IV: Practice Norms in Primary Hip and Knee Arthroplasty: What Is Everyone Else Doing? Moderator: Daniel J. Berry, MD
10:46 a.m. – 11:48 a.m. Session Four: InfectionModerators: Antonia F. Chen, MD MBA
Bryan D. Springer, MD
10:46 a.m.
Paper #22
Autoclave Efficacy on Contaminated Orthopedic Cement
Alberto V. Carli, MD, MSc
New York, NY
10:52 a.m.Paper #23
Extended Oral Antibiotics Is Protective Against Repeated PJI
Kenneth R. Urish, MD, PhD
Pittsburgh, PA
10:58 a.m.Paper #24
DAIR for Acute PJI: Results of 133 Primary THAs at Extended Follow-Up of 7 Years
Matthew P. Abdel, MD
Rochester, MN
11:04 a.m.DiscussionAll Faculty
11:14 a.m.
Paper #25
One-Stage vs. Two-Stage Treatment for PJI: A Prospective, Randomized Trial
Thomas K. Fehring, MD
Charlotte, NC
11:20 a.m.
Paper #26
Only 20% of TKA PJIs Meet Published Eligibility Criteria for One-Stage Exchange
Nicholas A. Bedard, MD
Rochester, MN
11:26 a.m.
Paper #27
Sobering Outcomes of Two-Stage Revision for PJI Among Patients with Revision TKA Components
Nathanael D. Heckmann, MD
Los Angeles, CA
11:32 a.m.Paper #28
Repeat Two-Stage Exchange Arthroplasty for Recurrent PJI of the Hip: Sobering Results
Aaron R. Owen, MD
Rochester, MN
11:38 a.m.DiscussionAll Faculty
11:48 a.m. – 12:48 p.m. Lunch for all attendeesExhibit Hall/Learning Center
Longhorn Exhibition Hall C–F
11:48 a.m. - 12:48 p.m.Arthroplasty Today (AT) Editorial Board LunchFort Worth 5-6
12:48 p.m. – 1:48 p.m. Keynote Session Damon West
1:48 p.m. – 2:48 p.m. Symposium V: Management of PJI: No Longer a “One Size Fits All” Two-Stage Exchange Moderator: Yale A. Fillingham, MD
2:48 p.m. – 3:08 p.m.BreakTexas Ballroom Foyer
3:08 p.m.AAHKS Presidential Award
Presented to: Gregory J. Golladay, MD
Presented by: James I. Huddleston III, MD
3:13 p.m.Lawrence D. Dorr, MD, Humanitarian Award
Presented to: TBA
Presented by: TBA
3:18 p.m.FARE Grant Awards
Presented to: TBA
Presented by: TBA
3:23 p.m.James A. Rand Young Investigators Award: “What is the Safest and Most Effective Dose of IV Dexamethasone in TKA? A Multicenter Prospective RCT”
Presented to: Charles P. Hannon, MD, MBA (Rochester, MN)

Presented by: Matthew P. Abdel, MD
3:29 p.m.AAHKS Surgical Techniques & Technologies Award: "Synovial Fluid Metal Ions: Diagnostic Markers for Aseptic Loosening in Cemented TKA” Presented to: J. Ryan Martin, MD (Nashville, TN)Presented by: James A. Browne, MD
3:35 p.m. AAHKS Clinical Research Award: “Intraosseous Regional Diclofenac for Post-Op Pain Management in TKA”
Presented to: Simon W. Young, MD (Auckland, New Zealand)
Presented by: Ran Schwarzkopf, MD, MSc
3:41 p.m.DiscussionAll Faculty
3:51 p.m. – 5:27 p.m. Session Five: Primary THA Moderators: Mark J. Spangehl, MD
Anna R. Cohen-Rosenblum, MD, MSc
3:51 p.m.Paper #29
Impact of Stem Designs in Periprosthetic Fracture Risk after Arthroplasty for Femoral Neck Fractures
Panayiotis Megaloikonomos, MD
Vancouver, Canada
3:57 p.m.Paper #30
Cementless Hemiarthroplasty Complication Risk Does Not Support Contemporary Utilization Patterns
Lucas A. Anderson, MD
Salt Lake City, UT
4:03 p.m.Paper #31
Is Bone Cement Implantation Syndrome Really Caused by Cement? A Review Using Bradford-Hill Criteria
James A. Browne, MD
Charlottesville, VA
4:09 p.m.Paper #32
Cementless Collared Metadiaphyseal-Filling Stems vs. Cemented Fixation for THA
Harpal S. Khanuja, MD
Baltimore, MD
4:25 p.m.Paper #33
Pre-Operative Surgical Prep Is Not Effective at Eliminating C. Acnes Prior to THA
Jason M. Jennings, MD
Denver, CO
4:31 p.m.Paper #34
Risk Factors for Wound Complications in Direct Anterior THA: A 10-Year Analysis
Joshua C. Rozell, MD
New York, NY
4:37 p.m.Paper #35
Three-Month Infection after Vancomycin and Iodine Irrigation in High-Risk THA and TKA: A Multicenter RCT
Ran Schwarzkopf, MD, MSc
New York, NY
4:43 p.m.Paper #36
Rapidly Progressive Osteoarthritis after Hip Corticosteroid Injection: You Must Exclude Infection
Adam J. Taylor, MD
Torrence, CA
4:49 p.m.DiscussionAll Faculty
4:59 p.m.Paper #37
Risk Factors for Dislocation After Direct Anterior THA
Murillo Adrados, MD
Roanoke, VA
5:05 p.m.Paper #38
Dislocated Dual-Mobility Hips: High Risk for Fail Closed Reduction with Increased Risk for Revision
Janyne L. Mallender, DO
Phoenix, AZ
5:11 p.m.Paper #39
Formal Physical Therapy Clearance is Not Necessary for Safe Home Discharge after Primary TJA
Sumon Nandi, MD, MBA
Baltimore, MD
5:17 p.m.Discussion All Faculty
5:27 p.m. – 6:27 p.m. Symposium VI: The Complex Primary THA: A Roadmap to a Successful Outcome Moderator: Ran Schwarzkopf, MD, MSc
6:27 p.m.Adjourn
Close Bitnami banner
Bitnami